Jesse Alderman

Sep 12, 2024 | jdsupra.com | Jesse Alderman

License hunters may have whiplash with state application processes in Kentucky, Minnesota, and Ohio (10(b) licenses) barely in the rearview mirror, but Delaware’s new license application deadline is fast approaching. Applications will be due September 30th. We detailed the requirements for applications in a lengthy post here.

Sep 12, 2024 | mondaq.com | Jesse Alderman

Cannabis practice co-chair Jesse Alderman spoke with the Boston Globe surrounding the firing of Massachusetts Cannabis Control Commission leader Shannon O'Brien, leaving multiple questions in its wake. Jesse commented on the existing bottom-up issues in the industry that remain unsolved in the industry and with the Commission even after this step was taken. Read the full article. (Subscription required) The content of this article is intended to provide a general guide to the subject matter.

Aug 9, 2024 | mjbizdaily.com | Jesse Alderman |Kate Lavin |Mike McQueeny

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)With the passage of Senate Bill 47, which legalized medical cannabis in the state, Kentucky is now on its way to becoming America’s next MMJ market. The success of Kentucky’s market will significantly depend on the state’s licensing process; the application submission period opened July 1 and closes Aug. 31.

May 30, 2024 | jdsupra.com | Jesse Alderman

On May 21, the Cannabis Control Commission quietly published a bulletin on its website that will immediately impact retailers already struggling to maintain footing in the competitive Massachusetts market.

May 14, 2024 | jdsupra.com | Jesse Alderman |Haider Andazola |Regina DeSantis

On April 30, 2024, the Associated Press (AP) reported the Drug Enforcement Administration (DEA) will propose a rule to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). More specifically, the Department of Justice (DOJ), which has authority over the DEA, submitted a formal rescheduling recommendation to the White House following an August 2023 recommendation from the Department of Health and Human Services (HHS) to the DEA to reschedule cannabis.